TipRanks
Veeva Systems (MX:VEEV)
:VEEV
Mexico Market

Veeva Systems (VEEV) Drug Pipeline

0 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Vp-102 / To-208, Vehicle / Vehicle
Warts, Common Warts, Common Warts (Verruca Vulgaris), Human Papilloma Virus (Hpv)
Phase III
Recruiting
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)
May 27, 2026
Vehicle, Vp-102
Warts, Common Warts, Common Warts (Verruca Vulgaris), Human Papilloma Virus (Hpv)
Phase III
Recruiting
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)
Nov 17, 2025

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Veeva Systems (VEEV) have in its pipeline
      VEEV is currently developing the following drugs: Vp-102 / To-208, Vehicle / Vehicle, Vehicle, Vp-102. These drug candidates are in various stages of clinical development as the company works toward FDA approval.